Chris Lau

Chris Lau

InvestorPlace Contributor

Expertise: Technology, Biotech

Expertise:

Technology
Biotech

Education:

Bachelor of Science
Project Management Professional

Awards and Accomplishments:

Top 100 Tipranks 2015-2021

About Chris:

Chris has over two decades of investing experience. He is an Honors B.Sc graduate (with distinction) in Science and Economics. He holds a Project Management Professional designation

Chris focuses on the technology, cyclical, and healthcare sector. He runs a newsletter with speculative Triple-baggers.

His investment strategy is based on finding undervalued stocks trading at a steep discount to their intrinsic value.

Follow Chris on DIY Value Investing.

Recent Articles

Nio Stock May Be Struggling, but That Means a Discount Is on the Way

By Chris Lau, InvestorPlace Contributor

China-stock de-listing fears and the EV bubble popping in February hurt Nio shares in the last two months.

Why SOS Stock Is Too Risky a Bitcoin Play To Handle

By Chris Lau, InvestorPlace Contributor

Short sellers are circling SOS stock as it boasts a fleet of hardware rigs ready to mine more of the valuable Bitcoin cryptocurrency.

Palantir Stock May Not Be a Great Short-Term Play, but Its Future Is Bright

By Chris Lau, InvestorPlace Contributor

PLTR stock volatility will hurt the price in the near-term, while the long-tail will lead to a strong, permanent lift in revenue.

Why AMC Entertainment Is a Wildly Worthwhile Speculative Trade

By Chris Lau, InvestorPlace Contributor

AMC stock benefited from a revival, as investors bet that the reopening of movie theaters will lift its prospects of survival.

7 Tech Stocks Desperate for an End to the Chip Shortage

By Chris Lau, InvestorPlace Contributor

Tech stocks are poised to benefit as the industry works through a severe chip shortage. As their output rises, profits will be set to grow.

Load More